Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Moleculin Biotech, Inc. | Director | Stock option (right to buy) | 14.7K | Nov 4, 2024 | Direct | ||
Clarus Therapeutics Holdings, Inc. | Director | Common Stock | 5.77K | Jun 7, 2022 | Direct | ||
Clarus Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 4.81K | Jun 7, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MBRX | Moleculin Biotech, Inc. | Nov 4, 2024 | 1 | $0 | 4 | Nov 6, 2024 | Director |
MBRX | Moleculin Biotech, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
MBRX | Moleculin Biotech, Inc. | Jun 20, 2022 | 2 | $0 | 4 | Jun 22, 2022 | Director |
CRXT | Clarus Therapeutics Holdings, Inc. | Jun 7, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
CRXT | Clarus Therapeutics Holdings, Inc. | Dec 12, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Director |
CRXT | Clarus Therapeutics Holdings, Inc. | Sep 9, 2021 | 0 | $0 | 3 | Sep 13, 2021 | Director |
MBRX | Moleculin Biotech, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |